Peter-Paul Emig

Title: The Innovations of Peter-Paul Emig

Introduction

Peter-Paul Emig is a notable inventor based in Bruchkobel, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of LH-RH antagonists. His work focuses on creating compounds that have improved action and fewer side effects.

Latest Patents

Peter-Paul Emig holds a patent for "LH-RH antagonists having improved action." This patent discloses new LH-RH antagonists, specifically peptidomimetics and peptides modified in a side chain. The patent also covers their salts with pharmaceutically acceptable acids and a process for preparing these LH-RH antagonists and their salts. The disclosed peptides are analogues of the luteinising hormone releasing hormone (LH-RH). These compounds exhibit high antagonistic power while being free of undesirable side effects, particularly edematogenic effects.

Career Highlights

Emig is associated with Asta Medica, Aktiengesellschaft, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of LH-RH antagonists in medical treatments.

Collaborations

Throughout his career, Peter-Paul Emig has collaborated with notable colleagues, including Bernhard Kutscher and Michael Bernd. These collaborations have further enhanced the impact of his research and innovations in the pharmaceutical industry.

Conclusion

Peter-Paul Emig's contributions to the field of pharmaceuticals, particularly through his patent on LH-RH antagonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.